EU governments ban malaria drug for Covid-19

European governments moved on Wednesday to halt the use of anti-malaria drug hydroxychloroquine to treat Covid-19 patients, and a second global trial was suspended, further blows to hopes for a treatment promoted by U.S. President Donald Trump.

The moves by France, Italy and Belgium followed a World Health Organization decision on Monday to pause a large trial of hydroxychloroquine due to safety concerns.

A UK regulator said on Wednesday that a separate trial was also being put on hold, less than a week after it started. The study, being led by the University of Oxford and partly funded by the Bill and Melinda Gates Foundation, was expected to involve as many as 40,000 healthcare workers.

"All hydroxychloroquine trials in Covid-19 remain under close review" while investigators assess any further risks, the Medicines and Healthcare products Regulatory Agency (MHRA) said in an email to Reuters.

Bütün xəbərlər Facebook səhifəmizdə

loading...